glucagon receptor retatrutide Science Behind GLP 1 GIP and Agonists for Obesity Research | News & Announcements What Does Current Research Suggest
Description
Among them, 7 are GLP-1R agonists, including 3 biosimilars of Semaglutide
Nat Med 2023;29:290918.ArticlePubMedPMCPDF 29
Rapid weight loss releases cholesterol into bile ducts, and GLP-1s may inhibit gallbladder motility
Recent research also indicates that GLP-1 analogs may play a role in treating chemical dependency, inhibiting dopaminergic release in the brains reward centers, decreasing withdrawal effects and relapses in animal models
Bear case: EVOKE shows no statistically significant difference on CDR-SB at two years and there is no Alzheimers label indication
